OIG Allows Drug Maker to Provide Free Eye Drops to Users of Certain Drug
- December 10, 2021
A pharmaceutical manufacturer’s proposed arrangement to provide free eye drops that mitigate side effects for patients using one of its products poses a sufficiently low risk of fraud and abuse under the Anti-Kickback Statute (AKS) and would not constitute grounds for the imposition of sanctions under the Beneficiary Inducements civil monetary penalty, the Department of Health and Human Services Office of Inspector General said in an advisory opinion posted December 6.
ARTICLE TAGS
You must be logged in to access this content.